SCHEMBL14017705

SCHEMBL14017705

CSc1ncnn2ccc(CNCCCNC(=O)OC(C)(C)C)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
CSNK2A2 P19784 1/20 0.39
CSNK2A1 P68400 1/20 0.39
AAK1 Q2M2I8 2/20 0.38
HTT P42858 1/20 0.38
STK17B O94768 1/20 0.37
STK17A Q9UEE5 1/20 0.37
CCNC P24863 1/20 0.37
CDK8 P49336 1/20 0.37
MET P08581 1/20 0.37
CA1 P00915 5/20 0.36
CA2 P00918 5/20 0.36
CA12 O43570 4/20 0.36
CA9 Q16790 4/20 0.36
CYP3A4 P08684 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
BRD4 O60885 1/20 0.35
PCSK9 Q8NBP7 1/20 0.35
DYRK1A Q13627 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4821294 0.86 MET (0.38) AAK1MET
SCHEMBL1683401 0.72 SCN9A (0.40) CSNK2A2CSNK2A1HTTMETCA1
SCHEMBL14017264 0.70 ERBB2 (0.38) AAK1
SCHEMBL4708016 0.68 MEN1 (0.52) MAOAMAOBHTTSTK17BSTK17A
SCHEMBL7110040 0.67 MAOA (0.57) MAOAMAOBCA1CA2CA12
SCHEMBL16152237 0.67 MAOA (0.54) MAOAMAOBSTK17BSTK17ACCNC
SCHEMBL6559442 0.66 ATM (0.55) MAOAMAOBCA1CA2CA12
SCHEMBL16152238 0.66 MAOA (0.52) MAOAMAOBSTK17BSTK17ACA1
SCHEMBL1557057 0.66 TDP1 (0.67) MAOAMAOBHTTSTK17BSTK17A
SCHEMBL2084315 0.66 MAOA (0.47) MAOAMAOBSTK17BSTK17ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7439246-B2 Fused heterocyclic kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-10-21 US disclosed
US-7439246-B2 Fused heterocyclic kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-10-21 US disclosed
US-7173031-B2 Pyrrolotriazine kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-02-06 US disclosed